medmix AG

SWX:MEDX Stock Report

Market Cap: CHF 424.2m

medmix Future Growth

Future criteria checks 3/6

medmix is forecast to grow earnings and revenue by 59.6% and 4% per annum respectively. EPS is expected to grow by 59.4% per annum. Return on equity is forecast to be 12.6% in 3 years.

Key information

59.6%

Earnings growth rate

59.4%

EPS growth rate

Medical Equipment earnings growth15.0%
Revenue growth rate4.0%
Future return on equity12.6%
Analyst coverage

Low

Last updated22 Jul 2024

Recent future growth updates

Recent updates

medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

Aug 11
medmix AG (VTX:MEDX) Looks Inexpensive After Falling 28% But Perhaps Not Attractive Enough

medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

Dec 19
medmix (VTX:MEDX) Is Reinvesting At Lower Rates Of Return

An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Oct 27
An Intrinsic Calculation For medmix AG (VTX:MEDX) Suggests It's 21% Undervalued

Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

Aug 16
Investors Could Be Concerned With medmix's (VTX:MEDX) Returns On Capital

There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

Feb 28
There May Be Reason For Hope In medmix's (VTX:MEDX) Disappointing Earnings

medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Jan 14
medmix (VTX:MEDX) May Have Issues Allocating Its Capital

Earnings and Revenue Growth Forecasts

SWX:MEDX - Analysts future estimates and past financials data (CHF Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202654033481132
12/31/202551630441062
12/31/20244912037962
6/30/2024480-21569N/A
3/31/2024483-1963N/A
12/31/20234870356N/A
9/30/20234815-347N/A
6/30/202347510-937N/A
3/31/202347611042N/A
12/31/202247712948N/A
9/30/2022478212257N/A
6/30/2022480313666N/A
3/31/2022468374676N/A
12/31/2021457445587N/A
9/30/2021435365690N/A
6/30/2021414285794N/A
3/31/2021382193272N/A
12/31/202035110851N/A
12/31/2019421255389N/A
12/31/2018454526494N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MEDX is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.3%).

Earnings vs Market: MEDX is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MEDX is expected to become profitable in the next 3 years.

Revenue vs Market: MEDX's revenue (4% per year) is forecast to grow slower than the Swiss market (4.4% per year).

High Growth Revenue: MEDX's revenue (4% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MEDX's Return on Equity is forecast to be low in 3 years time (12.6%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y